Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer
PaperCitations, authors & open-access status
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 85 citations, 2021 year and bronze oa status.
85
Citations
2021
Year
bronze
OA Status